Performance of JNJ Johnson & Johnson | -2.9% in 12m

Compare JNJ with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Johnson & Johnson with its related Sector/Index XLV

Compare Johnson & Johnson with its related Sector/Index XLV

Performance Duell JNJ vs XLV

TimeFrame JNJ XLV
1 Day 0.71% 0.83%
1 Week 1.58% 1.60%
1 Month -1.17% -0.13%
3 Months -4.83% -0.89%
6 Months -0.75% 11.98%
12 Months -2.85% 8.71%
YTD -4.31% 3.10%
Rel. Perf. 1m -0.18
Rel. Perf. 3m -0.85
Rel. Perf. 6m -1.29
Rel. Perf. 12m -1.17

Is Johnson & Johnson a good stock to buy?

Yes, based on ValueRay Fundamental Analyses, Johnson & Johnson (XETRA:JNJ) is currently (May 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 63.68 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JNJ as of May 2024 is 124.66. This means that JNJ is currently overvalued and has a potential downside of -9.98% (Sold with Premium).

Is JNJ a buy, sell or hold?

Johnson & Johnson has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of -2.85%.

In compare to Health Care Sector SPDR Fund, JNJ made -11.56% less over the last 12 months. Due to the underperformance, it is recommend to sell JNJ.
Values above 0%: JNJ is performing better - Values below 0%: JNJ is underperforming

Compare JNJ with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -1.44% -0.87% -19.96% -29.96%
US NASDAQ 100 QQQ -2.12% -1.11% -19.35% -39.79%
US Dow Jones Industrial 30 DIA -1.23% -1.13% -15.64% -20.71%
German DAX 40 DBXD -1.12% -1.66% -22.02% -17.93%
UK FTSE 100 ISFU -0.77% -5.34% -17.19% -13.58%
Shanghai Shenzhen CSI 300 CSI 300 -0.53% -5.01% -2.34% 9.26%
Hongkong Hang Seng HSI -4.22% -10.02% -1.10% 11.41%
Japan Nikkei 225 EXX7 -0.69% 1.82% -16.35% -22.19%
India NIFTY 50 INDA 2.42% -0.27% -18.17% -28.08%
Brasil Bovespa EWZ -3.22% -1.17% -5.19% -23.25%

JNJ Johnson & Johnson vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -2.95% 0.21% -21.52% -42.27%
Consumer Discretionary XLY -0.07% -0.05% -11.24% -24.66%
Consumer Staples XLP -0.08% -4.58% -13.60% -5.51%
Energy XLE 1.91% 3.19% -13.96% -23.05%
Financial XLF -0.53% 0.12% -24.36% -32.39%
Health Care XLV -0.02% -1.04% -12.73% -11.56%
Industrial XLI -0.75% -0.29% -24.83% -30.37%
Materials XLB -1.25% 0.66% -20.56% -20.00%
Real Estate XLRE -1.82% 2.16% -11.63% -7.09%
Technology XLK -2.49% -0.22% -18.07% -39.08%
Utilities XLU -2.62% -7.19% -16.30% -7.37%
Aerospace & Defense XAR -2.12% -3.35% -18.23% -28.36%
Biotech XBI -5.29% -1.20% -27.21% -9.26%
Homebuilder XHB -1.50% 1.36% -38.71% -52.67%
Retail XRT -1.72% -0.29% -22.09% -25.12%

JNJ Johnson & Johnson vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 5.25% 6.98% -5.90% -20.34%
Natural Gas UNG -10.40% -6.10% 38.09% 35.24%
Gold GLD 0.48% -0.12% -18.07% -16.98%
Silver SLV -2.04% 0.72% -20.96% -8.94%
Copper CPER 0.52% -7.61% -25.41% -21.61%

Returns of JNJ vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -1.64% -0.82% -5.83% 6.08%
iShares High Yield Corp. Bond HYG -0.12% -1.93% -8.11% -12.85%
Does Johnson & Johnson outperform its market, is JNJ a Sector Leader?
No, over the last 12 months Johnson & Johnson (JNJ) made -2.85%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.71%.
Over the last 3 months JNJ made -4.83%, while XLV made -0.89%.
Period JNJ XLV S&P 500
1 Month -1.17% -0.13% -0.30%
3 Months -4.83% -0.89% 4.15%
12 Months -2.85% 8.71% 27.11%